''Outstanding but also as expected - w knew that with a confirmed standardised dosage the figures should be the same or slightly better - they are slightly better... the two cohorts are now a combined 30 patients.''
How can one complete a 40c CR if true - if outstanding
A CR at 40c values KZA at $30m or less - outstanding you say
DYOR Newbies on funding at below market at each inflection point
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia paxalisib Phase II interim data
Ann: Kazia paxalisib Phase II interim data, page-10
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online